CRDF - Cardiff Oncology, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 2.19

Open

$ 2.22

Bid

$ 2.15 x 80

Ask

$ 2.41 x 2

Day's Range

$ 2.16 - $ 2.26

52 Week Range

$ 1.90 - $ 5.64

Volume

781,541

Average Volume

Market Cap

145.69M

Beta (5Y Monthly)

$ 1.36

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-29-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	03-02-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	02-25-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-27-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	03-06-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-03-2018	06-30-2018	10-Q
30	05-08-2018	03-31-2018	10-Q
31	02-26-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-15-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	03-10-2016	12-31-2015	10-K
40	11-09-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

A Glimpse Into The Expert Outlook On Cardi...
08/06/2025 13:02:22

amd-to-rally-more-than-20-here-are-10-top-analyst-forecasts-for-wednesday

AMD To Rally More Than 20%? Here Are 10 To...
08/06/2025 12:33:48

HC Wainwright & Co. Maintains Buy on Cardi...
08/06/2025 12:06:37

HC Wainwright & Co. analyst Robert Burns maintains Cardiff Oncology (NASDAQ:CRDF) with a Buy and lowers the price target...

why-is-cardiff-oncology-stock-trading-lower-after-colorectal-cancer-data

Why Is Cardiff Oncology Stock Trading Lowe...
07/30/2025 19:27:36

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of PF...

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 17:07:24

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 12:08:36

avis-budget-group-posts-downbeat-earnings-joins-sofi-technologies-seagate-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Avis Budget Group Posts Downbeat Earnings,...
07/30/2025 12:05:06

cardiff-oncology-shares-slide-over-26-in-premarket-trading-after-mixed-q2

Cardiff Oncology Shares Slide Over 26% In ...
07/30/2025 09:47:08

Cardiff Oncology Inc. (NASDAQ: CRDF) plummeted 22.96% in its stock value on Tuesday, following a disappointing second quarter e...

why-lendingclub-shares-are-trading-higher-by-around-23-here-are-20-stocks-moving-premarket

Why LendingClub Shares Are Trading Higher ...
07/30/2025 09:41:46

12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 21:06:19

Cardiff Oncology Reports 49% ORR With Onva...
07/29/2025 20:23:50

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-t...

Cardiff Oncology Q2 EPS $(0.21) Misses $(0...
07/29/2025 20:14:38

Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(...

Cardiff Oncology Announces Data From Ongoi...
07/29/2025 20:12:21

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-t...

Ladenburg Thalmann Initiates Coverage On C...
07/08/2025 18:44:55

Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Cardiff Oncology (NASDAQ:CRDF) with a Buy rating and announc...

this-makemytrip-analyst-turns-bullish-here-are-top-3-upgrades-for-tuesday

This MakeMyTrip Analyst Turns Bullish; Her...
06/24/2025 13:44:17

this-amylyx-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-4-initiations-for-tuesday

This Amylyx Pharmaceuticals Analyst Begins...
06/24/2025 12:29:58

Jefferies Initiates Coverage On Cardiff On...
06/24/2025 12:24:00

Jefferies analyst Maury Raycroft initiates coverage on Cardiff Oncology (NASDAQ:CRDF) with a Hold rating and announces Price...

12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 21:06:23

Cardiff Oncology Presents Data From Invest...
06/02/2025 20:11:00

– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonst...

HC Wainwright & Co. Maintains Buy on Cardi...
05/09/2025 13:09:30

HC Wainwright & Co. analyst Robert Burns maintains Cardiff Oncology (NASDAQ:CRDF) with a Buy and raises the price target...